INTRANASAL OXYTOCIN REDUCES CORE SYMPTOMS OF SCHIZOPHRENIA

被引：1
|
作者：
Feifel, David [1 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
SCHIZOPHRENIA RESEARCH | 2012年 / 136卷
关键词：
D O I：
10.1016/S0920-9964(12)70259-1
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [1] Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia Patients
    Feifel, David
    Macdonald, Kai
    Nguyen, Angel
    Cobb, Patrice
    Warlan, Heather
    Galangue, Barbara
    Minassian, Arpi
    Becker, Olga
    Cooper, Jason
    Perry, William
    Lefebvre, Mischelle
    Gonzales, James
    Hadley, Allison
    BIOLOGICAL PSYCHIATRY, 2010, 68 (07) : 678 - 680
  • [2] Intranasal Oxytocin Added Adjunct to Antipsychotics Reduces Symptoms of Schizophrenia
    Feifel, David
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 20S - 20S
  • [3] Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia
    Pedersen, Cort A.
    Gibson, Clare M.
    Rau, Shane W.
    Salimi, Kayvon
    Smedley, Kelly L.
    Casey, Robin L.
    Leserman, Jane
    Jarskog, L. Fredrik
    Penn, David L.
    SCHIZOPHRENIA RESEARCH, 2011, 132 (01) : 50 - 53
  • [4] Effects of intranasal oxytocin on symptoms of schizophrenia: A multivariate Bayesian meta-analysis
    Williams, Donald R.
    Buerkner, Paul-Christian
    PSYCHONEUROENDOCRINOLOGY, 2017, 75 : 141 - 151
  • [5] Intranasal oxytocin reduces hedonic eating in females
    Burmester, V.
    Terry, P.
    Bailey, A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (07) : 1642 - 1643
  • [6] The effects of adjunctive intranasal oxytocin in patients with schizophrenia
    Ota, Miho
    Yoshida, Sumiko
    Nakata, Masanori
    Yada, Toshihiko
    Kunugi, Hiroshi
    POSTGRADUATE MEDICINE, 2018, 130 (01) : 122 - 128
  • [7] Effects of intranasal oxytocin or galantamine for primary enduring negative symptoms and cognitive impairments in people with schizophrenia
    Kelly, D.
    Buchanan, R.
    McMahon, R.
    Gold, J.
    Feldman, S.
    August, S.
    Sullivan, K.
    Osing, J.
    Carpenter, W., Jr.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S131 - S131
  • [8] Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial
    Yamasue, Hidenori
    Okada, Takashi
    Munesue, Toshio
    Kuroda, Miho
    Fujioka, Toru
    Uno, Yota
    Matsumoto, Kaori
    Kuwabara, Hitoshi
    Mori, Daisuke
    Okamoto, Yuko
    Yoshimura, Yuko
    Kawakubo, Yuki
    Arioka, Yuko
    Kojima, Masaki
    Yuhi, Teruko
    Owada, Keiho
    Yassin, Walid
    Kushima, Itaru
    Benner, Seico
    Ogawa, Nanayo
    Eriguchi, Yosuke
    Kawano, Naoko
    Uemura, Yukari
    Yamamoto, Maeri
    Kano, Yukiko
    Kasai, Kiyoto
    Higashida, Haruhiro
    Ozaki, Norio
    Kosaka, Hirotaka
    MOLECULAR PSYCHIATRY, 2020, 25 (08) : 1849 - 1858
  • [9] Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial
    Hidenori Yamasue
    Takashi Okada
    Toshio Munesue
    Miho Kuroda
    Toru Fujioka
    Yota Uno
    Kaori Matsumoto
    Hitoshi Kuwabara
    Daisuke Mori
    Yuko Okamoto
    Yuko Yoshimura
    Yuki Kawakubo
    Yuko Arioka
    Masaki Kojima
    Teruko Yuhi
    Keiho Owada
    Walid Yassin
    Itaru Kushima
    Seico Benner
    Nanayo Ogawa
    Yosuke Eriguchi
    Naoko Kawano
    Yukari Uemura
    Maeri Yamamoto
    Yukiko Kano
    Kiyoto Kasai
    Haruhiro Higashida
    Norio Ozaki
    Hirotaka Kosaka
    Molecular Psychiatry, 2020, 25 : 1849 - 1858
  • [10] Intranasal oxytocin reduces attentional bias to food stimuli
    Burmester, V.
    Butler, G. K.
    Terry, P.
    APPETITE, 2022, 168
12345